Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study of deucrictibant tablets for prevention of hereditary angioedema attacks in adults and adolescents
AustriaStudy on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex
PolandStudy on Clindamycin and Rifampicin for Treating Infections in Patients with Obesity, Fracture-Related Infections, Hidradenitis Suppurativa, or Prosthetic Joint Infections
BelgiumStudy of Sonidegib for Patients with Nevoid Basal Cell Carcinoma Syndrome and Sporadic Basal Cell Carcinoma
ItalyStudy on Pembrolizumab for Patients with High-Risk Melanoma Without Signs of Metastasis
BelgiumStudy on [68Ga]Ga-FAPI-46 and Fludeoxyglucose (18F) PET/CT Imaging for Evaluating Treatment Response in Patients with Advanced Malignant Melanoma
DenmarkStudy on Stopping Nivolumab or Pembrolizumab in Advanced Melanoma Patients After Achieving a Response
The NetherlandsStudy on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy of TIL therapy combined with peginterferon alfa-2a and nivolumab for patients with metastatic melanoma
The NetherlandsStudy of nivolumab and ipilimumab combination therapy as an alternative to surgery and radiation in patients with skin squamous cell carcinoma
The NetherlandsStudy of MC2 TCR T Cell Therapy and Epigenetic Drug Treatment for Patients with Advanced Melanoma or Head and Neck Cancer
The NetherlandsStudy on Using Perflubutane for Sentinel Node Detection in Patients with Breast Cancer, Melanoma, or Head and Neck Cancer
The NetherlandsThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
